Similarly, postmenopausal obese patients with ER+/PR+ breast cancer had higher WBC counts than postmenopausal obese patients with ER−/PR− breast cancer [odds ratio (95% CI) = 1.342 (1.023–1.760), p = 0.034]. This evidence concerns the gene ESR1 and breast carcinoma.